Cooper Companies | COO - Eps Gewinn Pro Aktie

Aktienkurs
71.21
Täglich Wechseln
-0.25 -0.35%
Monatlich
-3.44%
Jährlich
-8.07%
Q2 Prognose
69.27

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q2 Apr/2026 1.1 0.96 May/28
FY2026Q1 Jan/2026 1.10 1.03 0.92 Mar/05
FY2025Q4 Oct/2025 1.15 1.11 1.04 Dec/04
FY2025Q3 Jul/2025 1.10 1.07 0.96 Aug/27
FY2025Q2 Apr/2025 0.96 0.93 0.45 May/29




Eps Veränderung Datum
Abbott USD 1.5 0.2 2025-12
Align Technology USD 3.29 0.68 2025-12
AtriCure USD 0.06 0.07 2025-12
Avanos Medical USD 0.29 0.07 2025-12
Bausch Health Companies USD 1.08 0.08 2025-12
Baxter International USD 0.44 0.25 2025-12
Bayer EUR 0.62 0.05 2025-12
Becton, Dickinson and Co. USD 2.91 1.05 2025-12
Boston Scientific USD 0.8 0.05 2025-12
Cooper Companies USD 0.66 0.26 2025-12
Dentsply International USD 0.06 0.44 2025-12
Dexcom USD 0.68 0.07 2025-12
Edwards Lifesciences USD 0.58 0.09 2025-12
Globus Medical USD 1.28 0.1 2025-12
Haemonetics USD 1.31 0.04 2025-12
Hologic USD 1.04 0.09 2025-12
Inogen USD -0.25 0.01 2024-09
Insulet USD 1.44 0.2 2025-12
Integra LifeSciences USD 0.83 0.29 2025-12
Intuitive Surgical USD 2.53 0.13 2025-12
J&J USD 2.46 0.34 2025-12
Medtronic USD 1.36 0.29 2026-01
Merit Medical Systems USD 1.04 0.12 2025-12
Novartis USD 1.54 0.48 2025-12
ResMed USD 2.81 0.26 2025-12
STAAR Surgical USD -0.37 0.53 2025-12
Steris USD 2.53 0.06 2025-12
Stryker USD 4.47 1.28 2025-12
Tandem Diabetes Care USD -0.01 0.3 2025-12
Teleflex USD 1.93 1.74 2025-12
Utah Medical Products USD 0.8 0.22 2025-12
Zimmer Biomet Holdings USD 2.42 0.52 2025-12